Podcasts about Medical research

The average British household usually puts on their central heating by October 24, according to British Gas. But this year, thanks to soaring energy costs, and a mild winter it may well be later. Turning down your heating can have real savings. The Energy Saving Trust calculates that turning your thermostat down from 20c to 19c should cut your energy bill by around 10 per cent. But as well as saving money there are possible health benefits. According to a study carried out by the Garvan Institute of Medical Research in Australia spending time in an environment at 19° increases your ‘brown fat'. This is unlike normal fat, because it is packed with mitochondria which act like mini power stations, turning food into energy. What are the health benefits? Should we go lower than 19°? Should anyone not turn down the temperature? In under 3 minutes, we answer your questions! To listen to the latest episodes, click here: ⁠Can you get rid of cellulite?⁠ ⁠Do you know about home design maximalism?⁠ ⁠What is toxic positivity?⁠ A Bababam Originals podcast, written and produced by Amber Minogue. First Broadcast: 15/11/2022 Learn more about your ad choices. Visit megaphone.fm/adchoices

What if inflammation isn't something to "fight"… but a signal your nervous system can't turn off? In this powerful conversation, I'm joined by Kevin J. Tracey, MD — President and CEO of The Feinstein Institutes for Medical Research and a global leader in neuroimmunology and bioelectronic medicine. Dr. Tracey is best known for discovering the inflammatory reflex — the neural circuit through which the vagus nerve actively regulates the immune system. His work changed how we understand inflammation, chronic disease, recovery, and healing itself. And for high-performing, driven, midlife athletes and professionals… this science explains why so many people are stuck. In this episode, we connect Dr. Tracey's groundbreaking research directly into my FLOW Foundation™ framework:

This review series focuses on recent advances in resolving macro and molecular structures that have driven the field of occlusive thrombus structure and function forward. Covering multiple contributions to thrombosis, eg, platelets, factor XIII, and the contact system, the series also looks to put this new knowledge into the context of future advances in diagnostic and therapeutic tools to enhance normal hemostasis while preventing and treating unwanted thrombosis. Blood Associate Editor, Dr. Thomas Ortel discusses this series with Drs. Alisa Wolberg, Jonas Emsley, and John Weisel, who all contributed to articles in the Review Series on the Structural Underpinnings of Hemostatic Plugs and Thrombotic Occulsions which can be found in volume 146, issue 12 of Blood. 

In this episode of Better Thinking, Nesh Nikolic speaks with Professor Philip Batterham about advancing more efficient and precise methods for assessing suicidality and mental disorders.Philip Batterham is a Professor and Co-Head at the Centre for Mental Health Research, The Australian National University in Canberra, Australia. Phil is a research leader in improving access to evidence-based support for mental ill health and suicidal thoughts. He has specific interests in the etiology of suicidal behaviour, assessment of suicidality and mental disorders, implementation of online prevention programs, and reducing barriers to help seeking. Phil has published 320 journal articles and received >$50M in research funding as a Chief Investigator. He has received national and international awards for his research, including the Commonwealth Health Minister's Award for Excellence in Health and Medical Research, the Professor Vera Morgan Medal for Mental Health Epidemiology, and the inaugural NHMRC Peer Review Excellence Award. He currently leads a major longitudinal cohort study to better understand transitions into suicidal behaviour.

This week, we explore a new standard of care for high-risk HER2-positive early breast cancer, long-acting therapy for people with HIV facing adherence challenges, a first-in-class trial of a p53 reactivator, and tecovirimat for mpox. We review group B streptococcal disease and a revealing case of prosthetic joint infection. Perspectives examine the role of folate therapy, Medicare drug-price negotiation, AI in medical education, and incidental findings.

In the second part of this 20-Minute Health Talk podcast with Peter Hotez, MD, pediatrician, scientist and global health advocate, the conversation with host Chethan Sathya, MD, shifts to the front lines of health care. Dr. Hotez offers practical advice for clinicians and the public on navigating medical misinformation and myths, such as "turbo cancers.” He also reveals yet another good reason to get your Covid and flu shots — to protect your heart. As he explores the critical public health importance of childhood vaccines like the MMR and Hepatitis B, Dr. Hotez explains the real-world consequences of declining vaccination rates. Finally, he offers his frank assessment of the political and financial forces driving the anti-science movement and how to rebuild public trust. This is Part 2 of this series. Listen to Part 1 About Northwell Health Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch more episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. 

In this episode of 20-Minute Health Talk, host Chethan Sathya, MD, speaks with Peter Hotez, MD, pediatrician, scientist and global health advocate. Dr. Hotez shares the story behind his public advocacy: The "planned part" of his career — developing life-saving vaccines for the world's poor — and the "unplanned part" that began when his daughter, Rachel, was diagnosed with autism. Dr. Hotez explains how this experience thrust him into the center of the vaccine debate, which led to him becoming a target of the anti-vaccine movement. He and Dr. Sathya offer a behind-the-scenes look at the challenges of communicating evolving science to the general public. This is Part 1 of this series. Listen to Part 2 About Northwell Health Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch more episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. 

Reflections on the Peter Attia/Epstein scandal; How to lower lp(a)—does diet help? What are bio-active peptides? Could they stave off kidney disease? Scientists just tested the fittest 81-year-old in the world—here's what they found; Media erroneously report that intermittent fasting is not effective for weight loss; Sugary drinks may stoke anxiety in teens; Omega-3s support kids' reading fluency and spelling scores; Surprising study shows saturated fats not harmful to kidneys.

Vitamin D testing is vital for tailoring doses to optimize health—but regulators are conducting a campaign to deny coverage; Can magnesium be taken simultaneously with blood pressure meds? Lifelong learning delays Alzheimer's onset by 5 years; Your MRI says you have a bum shoulder—but 99% of people show abnormalities even when they have no discomfort; Saunas can help stave off dementia. 

Before he was even born, Sarah and Ross Gray knew that their son Thomas wouldn't live long. But as they let go of him, they made a decision that reverberated through a world that they never bothered to think about. Years later, after a couple of awkward phone calls, they go on a quest and manage to meet the people and places for whom Thomas' short life was an altogether different kind of gift. We originally made this story back in 2015, but we wanted to play it again because we love that it brings a view of science that is redemptive, tender, and unexpected. Since we first released this episode, Sarah Gray wrote a book called A Life Everlasting (https://zpr.io/GVYisRaqe9d6), it's a memoir about Thomas that dives into the world of organ donation and medical science. She's also written a beautiful short story about shame called The Lacemaker Fairy Tale (https://zpr.io/Li5BMtfHmf92). And, right now she's working on a script for a movie called Raincheck.EPISODE CREDITS: Reported by - Jad Abumrad with help from - Latif NasserLATERAL CUTS - The Cathedral (https://radiolab.org/podcast/cathedral) The Immortal Life of Henrietta Lacks (https://radiolab.org/podcast/the-immortal-life-of-henrietta-lacks)  Signup for our newsletter!! It includes short essays, recommendations, and details about other ways to interact with the show. Sign up (https://radiolab.org/newsletter)! Radiolab is supported by listeners like you. Support Radiolab by becoming a member of The Lab (https://members.radiolab.org/) today. Follow our show on Instagram, Twitter and Facebook @radiolab, and share your thoughts with us by emailing radiolab@wnyc.org. Leadership support for Radiolab's science programming is provided by the Simons Foundation and the John Templeton Foundation. Foundational support for Radiolab was provided by the Alfred P. Sloan Foundation.

Antimicrobial resistance, or AMR, is often described as a silent pandemic. With antibiotics losing their effectiveness due to overuse and misuse, we look at how serious India's AMR burden is and why drug-resistant infections are rising. The Indian Express' Rinku Ghosh and Shashank Bhargava speak with Dr Kamini Walia of the Indian Council of Medical Research about what is driving this crisis and what can be done to slow it.Hosted by Ichha SharmaProduced and written by Shashank Bhargava and Ichha SharmaEdited and mixed by Suresh Pawar

Face transplant patient Robert Chelsea and writer Fay Bound Alberti talk through the promise – and darker side – of this pioneering surgery. Help support our independent journalism at theguardian.com/infocus

This week, we highlight major advances in multiple myeloma, gene therapy for cystinosis, and experimental treatments for myotonic dystrophy. We review long-term outcomes of aortic-valve replacement, strategies for secondary stroke prevention, and a revealing diagnostic case of eosinophilic disease in an older adult. A Sounding Board explores FDA approval standards. Perspectives delve into tobacco cessation, influenza evolution, and the uncertainty patients and clinicians share when facing life-altering diagnoses.

In this week's episode, Blood editor Dr. Laurie Sehn interviews authors Drs. Anastasios Karadimitris and Maria Carolina Florian on their papers published in Volume 147 Issue 2 of Blood. Dr. Karadimitris' paper "Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia", discusses the success of bispecific CAR-iNKT cells targeting CD19 and CD133 in pre-clinical models, prompting the clinical development of this class of product. Dr. Florian's paper, "A Notch trans-activation to cis-inhibition switch underlies hematopoietic stem cell aging" proposes that the Jagged2/Notch interaction is a key regulator of hematopoietic stem cell divisional symmetry during aging and offers insights that may inform strategies to restore regenerative function in aged hematopoiesis. 

This week includes studies on promising new therapies for IgA nephropathy, evolving antithrombotic strategies after coronary stenting, and the inciting antigen in rare vaccine-related clotting syndromes. We review the urgent challenge of mucormycosis and follow the case of a young woman with headaches and hypertension. We discuss human-subjects research. Perspectives examine rural health, data interoperability, drug labels in the courts, and a pediatrician's dilemma.

In part three of Northwell's 20-Minute Health Talk podcast, host Chethan Sathya, MD, and Jerome Adams, MD, former US Surgeon General, discuss the critical role of empathy and shared decision-making in healthcare communication, especially as public trust wavers. Amid rising frustrations with the healthcare system, Dr. Adams stresses the need for healthcare professionals to use empathetic, evidence-based dialogue to rebuild trust. He highlights the need for systemic change, advocating community engagement and upstream interventions in lieu of a mere sick-reimbursement model. He further reflects on his career trajectory and encourages aspiring physician leaders to leverage their credibility to make positive contributions, emphasizing continuous learning and adaptability in the evolving public health landscape. This is Part 3 of this series. Listen to Part 1 Listen to Part 2 About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. 

In the second episode of Northwell's 20-Minute Health Talk podcast with Jerome Adams, MD, he and host Chethan Sathya, MD, discuss the pivotal role of election-year dynamics in shaping national and regional responses to the COVID-19 pandemic. Dr. Adams reflects on the challenge of balancing economic impacts with health mandates amid a politically charged atmosphere and how decision-making was swayed by partisan pressures. He highlights the importance of nuanced public health communication and the urgent need for healthcare professionals to prioritize empathy and understanding in patient interactions to convey crucial health information effectively. This is Part 2 of this series. Listen to Part 1 Listen to Part 3 About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. 

Host Chethan Sathya, MD, welcomes Jerome Adams, MD, US Surgeon General from 2016 to 2021 and author of Crisis and Chaos: Lessons from the Front Lines of the War Against Covid-19. In part one of this three-part series, Dr. Adams shares his journey from humble beginnings in rural Maryland to becoming a prominent public health leader. Despite facing personal health challenges and systemic barriers, Dr. Adams reflects on his resilient pursuit of a medical career, leading during Covid and his commitment to mentoring the next generation of health providers. He also discusses his experiences within the first Trump administration, the importance of representation in medicine and the critical need for diverse voices in public health discussions. This is Part 1 of this series. Listen to Part 2 Listen to Part 3 About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. 

In this episode, Giovanni Piedimonte, MD, FAAP, FCCP, Professor of Pediatrics, Biochemistry, and Molecular Biology at Tulane University School of Medicine, discusses how artificial intelligence is transforming research, clinical care, and academic medicine. He also discusses the risks, ethical challenges, and workforce implications health systems must prepare for as AI adoption accelerates.

Send us a textUniversity of Maryland School of Medicine (UMSOM) associate professor Sarah M. Kattakuzhy, MD, joins “The UMB Pulse” this month to talk about her research exploring whether semaglutide (a GLP-1 medication widely used for diabetes and weight management) could help reduce cravings and improve outcomes for people with stimulant use disorder.Kattakuzhy, who is also the co-director of the Kahlert Institute for Addiction Medicine at UMSOM, describes the design of the STAC Study, which is evaluating the safety and tolerability of semaglutide in people with cocaine use disorder, including participants with and without HIV, while also tracking secondary outcomes such as changes in drug use and cravings.She also discusses why stimulant use disorders, including cocaine and methamphetamine use disorder, have been especially challenging to treat, and how her work through the University of Maryland, Baltimore community-based research partnerships aims to expand treatment options and reduce stigma around substance use disorders.To learn more about this trial or for referrals, contact Dr. Kattakuzhy at skattakuzhy@ihv.umaryland.edu.00:00 Introduction to Addiction and New Research00:40 Meet Dr. Sarah Kattakuzhy01:45 A Day in the Life of Dr. Kattakuzhy03:57 The Journey to Addiction Research07:40 Exploring Semaglutides for Addiction Treatment12:34 Details of the Clinical Trial20:29 Challenges and Hopes in Addiction Treatment24:31 Collaborations and Future Directions27:39 Final Thoughts and Takeaways32:13 Post-Interview InsightsListen to The UMB Pulse on Apple, Spotify, Amazon Music, and wherever you like to listen. The UMB Pulse is also now on YouTube.Visit our website at umaryland.edu/pulse or email us at umbpulse@umaryland.edu.

In this week's episode, Blood editor Dr. James Griffin interviews Drs. Paresh Vyas and Andrew Hantel on their research published in this week's issue of Blood. Dr. Vyas discusses his paper, "Rapid clonal selection within early hematopoietic cell compartments presages outcome to ivosidenib combination therapy", which provided new insights as to when and how to intervene to circumvent resistance to AML remission. Dr. Hantel will speak about his paper, "Impact of Modernizing Eligibility Criteria on Enrollment and Representation in AML Clinical Trials". For a real-world cohort of more than 2200 patients with AML, they reported that modernized, safety-based criteria could nearly double trial eligibility, with especially pronounced gains among historically underserved groups.  Both studies highlight how biologic insight and thoughtful trial design can drive more effective, inclusive advances in AML treatment and research. 

This week, we look at new evidence on oral cholesterol-lowering therapy, the evolving role of beta-blockers after myocardial infarction, and advances in breast and prostate cancer treatment. We review the inherited risk of coronary disease. We also work through a revealing diagnostic case in a young woman and reflect on science under pressure, corporatized insurance, the reach of FDA law, and what it means to live with life-sustaining technology.

In this episode, Giovanni Piedimonte, MD, FAAP, FCCP, Professor of Pediatrics, Biochemistry, and Molecular Biology at Tulane University School of Medicine, discusses how artificial intelligence is transforming research, clinical care, and academic medicine. He also discusses the risks, ethical challenges, and workforce implications health systems must prepare for as AI adoption accelerates.

Is modern medicine still evidence-based, or have we quietly mistaken rigor for certainty?Evidence-based medicine is essential. It's why we save lives, advance care, and trust modern healthcare. But as medicine has become more specialized and disease more complex, something subtle has happened. Rigor has increasingly turned into reductionism, and evidence is often applied in ways that don't fully match the realities of clinical practice or patients' lived experiences.In this episode of The Trip Lab, I take a careful look at what we mean when we say “evidence-based medicine.” We explore the difference between statistical significance and clinical significance, how guidelines are created and why they are evidence-informed rather than infallible, and why many patients feel unwell despite having “normal” labs.This conversation also examines how modern research methods struggle to capture complexity, particularly in chronic, system-level disease. We look at where reductionism has helped medicine advance, where it now falls short, and why ancient healing systems and emerging fields like systems biology, functional medicine, and precision medicine are pointing us toward a more integrated future.This episode is not a rejection of evidence. It's an invitation to reclaim it. To restore clinical wisdom alongside data, and to practice medicine with both rigor and curiosity.In this episode, we cover:What “evidence-based medicine” actually means and how it's evolvedStatistical significance vs. clinical significanceThe strengths and limitations of medical guidelinesWhy reductionist models don't fully explain chronic diseaseWhy patients can feel unwell even when labs are “normal”How medicine might evolve to better study complexityWhy medicine is both a science and an artThe podcast name, The Trip Lab, nods to psychedelics, but a “trip,” psychedelic or otherwise, is ultimately an exploration. A willingness to step outside familiar frameworks, question what we think we know, and notice connections that weren't obvious before.If you've ever felt tension between what the data says, what the guidelines allow, and what the patient in front of you actually needs... or if you are a patient who has been failed by modern medicine, this episode is for you.

From COVID-19 research to Parkinson's disease therapies, these statistical experts turn numbers into answers, helping doctors make evidence-based decisions that improve patient care.

Last year, the National Institutes of Health drastically cut funding for medical research. This disrupted the work of academics and researchers across the country. Clinical trials and scientific projects were cancelled, and funding for ongoing research was revoked. This meant big cuts in funding to research institutions here in Connecticut. UConn lost $41 million from research grant terminations and unexpected non-renewals. Today, we hear how these cuts are impacting research institutions in our state and the future of science. GUESTS: Rob Stein: Correspondent and Senior Editor, on NPR’s Science Desk Evan Morris: Professor of Radiology and Biomedical Imaging and of Biomedical Engineering at Yale School of Medicine Diane Owens: mother of a pediatric patient with neurofibromatosis Support the show: http://wnpr.org/donateSee omnystudio.com/listener for privacy information.

In this week's episode, Blood Associate editor Dr. Hervé Dombret interviews authors Drs. Sarah K. Tasian and David T. Teachey on their contributions to the How I Treat Series on acute lymphoblastic leukemia. Dr. Tasian's paper, “How I treat Philadelphia chromosome-like acute lymphoblastic leukemia in children, adolescents, and young adults” discusses the different classes of Ph-like ALL and reviews the recent trials investigating TKIs and immunotherapy specifically for this high-risk patient population. Dr. Teachey's paper, “How I treat ETP-ALL in children”, discusses the best current and emerging therapies that may be used in patients with ETP ALL, including nelarabine and other new agents, immunotherapy, and allogeneic HSCT.See the full How I Treat series in volume 145 issue 1 of Blood.

This week, we explore new therapies to reduce pancreatitis risk in severe hypertriglyceridemia, advances in breast cancer treatment, and long-term results of gene therapy for hemophilia B. We discuss vision-threatening vascular emergencies, the mental health effects of firearm injury on families, and care for peripheral artery disease. We also follow a revealing diagnostic case in an older woman with respiratory failure. Perspectives reflect on hypertension control, immunization access, chronic disease policy, and on the inherited risk of disease.

In the final segment of this three-part series, host Chethan Sathya, MD, and former NYC Health Commissioner Ashwin Vasan, MD, discuss the critical need for rebuilding trust in public health. Dr. Vasan emphasizes the importance of open dialogue and empathetic engagement across communities, highlighting the challenges posed by societal divisions. As public health faces skepticism, he underscores the need to involve diverse perspectives to foster unity and chart a path toward a healthier, more inclusive future. This is Part 3 of this series. Listen to Part 1 Listen to Part 2 About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. 

Join host Chethan Sathya, MD, and former NYC Health Commissioner Ashwin Vasan, MD, for part two of our series exploring public health challenges. In this segment, Dr. Vasan addresses the opioid crisis, his leadership during tumultuous times, and the essential role of resilience. He shares insights from his diverse roles, highlighting the successful reduction in overdose deaths and how volatility spurred transformative strategies, ranging from mental health initiatives to efforts to tackle social media's impact. This is Part 2 of this series. Listen to Part 1 Listen to Part 3 About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. 

Host Chethan Sathya, MD, discusses the challenges and opportunities of improving public health with the former commissioner of NYC's Department of Health and Mental Hygiene, Ashwin Vasan, MD. In this 3-part conversation, Dr. Vasan delves into his inspiring journey into medicine. With family tragedies, namely polio, and successes fueling his passion, Dr. Vassan discusses the vital role of storytelling in enacting systemic change. Guided by influential mentors, he emphasizes the need for engagement, empathy, and impactful results in public health initiatives. This is Part 1 of this series. Listen to Part 2 Listen to Part 3 About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. 

New Australian research confirms people with ME/CFS have a consistent faulty cellular structure. Could this be a turning point in diagnosis?

In this episode, we explore evolving evidence on anticoagulation after atrial fibrillation ablation, long-term outcomes with immunotherapy for melanoma, and promising new treatments for hepatitis D and triple-negative breast cancer. We review advances in physiologic pacing for heart failure and work through a challenging case involving fever, rash, and neurologic symptoms. An article considers fairness for late-career physicians, and Perspectives discuss misconceptions about autism, access to contraception, and the financial pressures shaping health care.

The rapid progression of artificial intelligence is transforming medical research and healthcare, paving the way for even more transformative innovations on the horizon. Discover The Progression & Transformation of AI in Medical Research & Healthcare…inside this edition of CTSI Discovery Radio!

In this week's episode, Blood Associate editor Dr. Thomas Ortel interviews authors Drs. Ware Branch and J.J. Strouse on their contributions to How I Treat hematologic complications in pregnancy. Dr. Branch's paper, “How I diagnose and treat antiphospholipid syndrome in pregnancy” discusses the evolving clinical and laboratory features of APS, and the treatment of cases meeting ACR/EULAR classification criteria. Dr. Strouse stresses the unique problems posed to both the mother and fetus during pregnancy in his paper "How I treat sickle cell disease in pregnancy”.See the full How I Treat series in volume 143 issue 9 of Blood journal. 

This week, we explore new evidence on managing asymptomatic carotid stenosis, restoring vision in advanced macular degeneration, and preventing migraine in children. We discuss innovative cellular therapy for autoimmune disease, review sudden cardiac arrest in athletes, and describe a case of severe systemic infection with vision loss. Perspectives examine global tobacco risks, the future of telehealth payment, Medicare coverage of new technologies, and the things physicians carry.

In part two of "Navigating Breast Cancer," host Sandra Lindsay continues the conversation with breast cancer surgeon Susan K. Boolbol, MD. They explore the options of lumpectomy and mastectomy, as well as the evolution of surgical techniques aimed at improving aesthetic outcomes. Delving into the psychological and emotional aspects of recovery, Dr. Boolbol emphasizes the importance of community support and proactive care; she underscores the need for early diagnosis to improve long-term survival, while highlighting the overall positive outlook for women affected by the disease. This is Part 2 of this series. Listen to Part 1 About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. 

Ian Sample puts listeners' questions on sleep to Dr Allie Hare, consultant physician in respiratory and sleep medicine at Guy's and St Thomas' hospitals and president of the British Sleep Society. They cover why women experience sleep disturbance during the menopause, why sleep paralysis affects some people more than others, and what scientists know about the link between sleep and dementia. Hare also gives her top tips for getting better sleep in 2026. Help support our independent journalism at theguardian.com/sciencepod

When neuroscientist Madeline Lancaster was a brand new postdoc, she accidentally used an expired protein gel in a lab experiment and noticed something weird. The stem cells she was trying to grow in a dish were self-assembling. The result? Madeline was the first person ever to grow what she called a “cerebral organoid,” a tiny, 3D version of a human brain the size of a peppercorn.In about a decade, these mini human brain balls were everywhere. They were revealing bombshell secrets about how our brains develop in the womb, helping treat advanced cancer patients, being implanted into animals, even playing the video game Pong. But what are they? Are these brain balls capable of sensing, feeling, learning, being? Are they tiny, trapped humans? And if they were, how would we know?Special thanks to Lynn Levy, Jason Yamada-Hanff, David Fajgenbaum, Andrew Verstein, Anne Hamilton, Christopher Mason, Madeline Mason-Mariarty, the team at the Boston Museum of Science, and Howard Fine, Stefano Cirigliano, and the team at Weill-Cornell. EPISODE CREDITS: Reported by - Latif Nasserwith help from - Mona MadgavkarProduced by - Annie McEwen, Mona Madgavkar, and Pat Walterswith mixing help from - Jeremy BloomFact-checking by - Natalie Middleton and Rebecca Randand Edited by  - Alex Neason and Pat WaltersEPISODE CITATIONS:Videos - “Growing Mini Brains to Discover What Makes Us Human,” Madeline Lancaster's TEDxCERN Talk, Nov 2015 (https://zpr.io/6WP7xfA27auR)Brain cells playing Pong (https://zpr.io/pqgSqguJeAPK)Reuters report on CL1 computer launch in March 2025 (https://zpr.io/cdMf8Yjvayyd) Articles - Madeline Lancaster: The accidental organoid – mini-brains as models for human brain development (https://zpr.io/nnwFwUwnm2p6), MRC Laboratory of Molecular Biology What We Can Learn From Brain Organoids (https://zpr.io/frUfsg4pxKsb), by Carl Zimmer. NYT, November 6, 2025Ethical Issues Related to Brain Organoid Research (https://zpr.io/qyiATHEhdnSa), by Insoo Hyun et al, Brain Research, 2020 Brain organoids get cancer, too, opening a new frontier in personalized medicine (https://zpr.io/nqMCQ) STAT Profile of Howard Fine and his lab's glioblastoma research at Weill Cornell Medical Center: By re-creating neural pathway in dish, Stanford Medicine research may speed pain treatment (https://zpr.io/UnegZeQZfqn2) Stanford Medicine profile of Sergiu Pasca's research on pain in organoids A brief history of organoids (https://zpr.io/waSbUCSrL9va) by Corrò et al, American Journal of Physiology - Cell Physiology, Books - Carl Zimmer Life's Edge: The Search for What it Means to be Alive (https://carlzimmer.com/books/lifes-edge/)Sign up for our newsletter!! It includes short essays, recommendations, and details about other ways to interact with the show. Signup (https://radiolab.org/newsletter)!Radiolab is supported by listeners like you. Support Radiolab by becoming a member of The Lab (https://members.radiolab.org/) today.Follow our show on Instagram, Twitter and Facebook @radiolab, and share your thoughts with us by emailing radiolab@wnyc.org.Leadership support for Radiolab's science programming is provided by the Simons Foundation and the John Templeton Foundation. Foundational support for Radiolab was provided by the Alfred P. Sloan Foundation.

This week's episode accompanies the Review Series on Marginal Zone Lymphoma published in this week's issue of Blood. Associate editor, Dr. Philippe Armand interviews authors Dr. Juan Pablo Alderuccio and Dr. Ariela Noy on their contribution to this review series titled "The treatment of marginal zone lymphoma". The article is crucial in highlighting the clinically and biologically heterogenous nature of MZL diseases, and how current treatment options and available research do not allow for comprehensive MZL specific therapies. Drs. Alderuccio and Noy share their insights on specific avenues for the expansion of the MZL care landscape. Find the full review series in volume 147 issue 2 of Blood journal.

This week, we explore new options in cardiovascular prevention, fish-oil supplementation in dialysis patients, RSV vaccination, and cutting-edge cellular therapy for leukemia. We discuss advances in lung cancer treatment, approaches to functional dyspepsia, and a complex case of severe infection after travel. Perspectives examine access to and cost of weight-loss drugs, the promise and risks of AI in clinical care, and what it means to care for others while carrying personal loss.

More than 300,000 women in the United States are diagnosed with breast cancer each year, a stunning number given how much confusion exists around screening and treatment. In this episode, 20-Minute Health Talk host Sandra Lindsay discusses the powerful role of early detection in saving women's lives with Susan K. Boolbol, MD, FACS, the system chief of breast surgical oncology and breast program at Northwell/Nuvance Health. Dr. Boolbol also addresses some of the myths surrounding breast cancer and sheds light on dense breasts, biopsy misconceptions, and the importance of proactive care. About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. 

In the last year, you've basically replaced your body weight in new cells. So yes, it's a new year, new you. To ring in 2026, we're talking about starting anew, and drawing inspiration from tiny worms that embody the ultimate growth mindset—they can regrow a whole body from just a tiny piece of their tail. In this festive episode, Host Flora Lichtman talks with biologist Alejandro Sánchez Alvarado, a pioneer in the field of regeneration, about the science of regeneration and the biology lessons we can carry into the new year. Guest: Dr. Alejandro Sánchez Alvarado is a biologist and president and chief scientific officer of the Stowers Institute for Medical Research in Kansas City, Missouri.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

In this week's episode we've pulled a vault recording from 2025! Blood editor Dr. Laurie Sehn interviews authors Drs. David-Alexandre Trégouët and Johannes Schetelig on their research published in volume 146 issue 19 of Blood journal. Dr. Trégouët's study conducted a genome-wide association study supplemented by transcriptome and Mendelian randomization analyses to identify 28 loci and proteins associated with VTE recurrence risk. This work provides genomic evidence that inherited variants contribute to the risk of VTE recurrence, raising the possibility of a more personalized approach to the prevention of recurrent VTE. The study conducted by Dr. Schetelig and colleagues report the results of a long term trial on patients with poor-response AML, comparing outcomes between patients who received salvage chemotherapy versus immediate transplantation. With no difference in survival rates at 5 years, outcomes seem to be determined mainly by genetic risk factors, age, and comorbidities, therefore challenging the routine use of intensive remission induction before allogeneic transplant in patients with an available donor and underscore the need for novel therapeutic strategies for poor-risk AML.Featured Articles:Molecular Determinants of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial 

This week, we share advances in treatment for EGFR-mutated lung cancer, a brain-penetrant enzyme therapy for a rare pediatric disorder, and dual targeting of extramedullary myeloma. We review cardiogenic shock, work through a challenging diagnostic puzzle in a young woman with recurrent illness, and explore Perspectives on corporatized care, vaccine policy, AI in medicine, and where clinicians carry grief.

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com Recognizing that life has an expiration date makes both medicine and risk-taking more meaningful, and that insight runs through this entire conversation.  In this episode, Dr. Orvil Martinez, CEO of the Advanced Medical Research Center, and Dr. Felix Rivera, owner of US Neurology Consulting, discuss how their Puerto Rican roots, love of adventure, and passion for technology influence their medical practice and vision for the future of healthcare. They share wild stories of skydiving from airplane wings, bungee jumping over concrete, and near-fatal injuries, set against the backdrop of their lives as thoughtful clinicians, parents, and technophiles. The conversation then turns to AI's potential to ease primary care burdens in Puerto Rico, support tele-neurology, reduce overhead, and sustain independent practice. They close by unveiling plans for the island's first AI Congress in November 2026, underscoring that innovation, trust, and accepting mortality are essential to living fully. Tune in and learn how personal risk, family roots, and bold AI vision are converging to reshape care in Puerto Rico and beyond! Resources Connect with and follow Dr. Orvil Martinez on LinkedIn. Visit the Advanced Medical Research Center website. Follow and connect with Dr. Felix Rivera on LinkedIn.

This week, we look at ctDNA-guided immunotherapy for bladder cancer, cardiovascular outcomes with tirzepatide, and evidence that one HPV vaccine dose may be enough. We explore high-dose rifampin for tuberculous meningitis, review measles amid rising outbreaks, and follow a challenging case of gastrointestinal bleeding. Essays examine how clinicians navigate post-Dobbs care, tobacco harm among people with mental illness, congenital syphilis, and sustaining medical research.

Antioxidants and resistance training for treatment of sarcopeniaAnabolic resistance with advancing ageAre there any holistic medicine approaches to treating Lewy Body Syndrome?Is canned fish like sardines safe to eat?

Maryanne Demasi is an independent investigative journalist based in Australia and a former medical scientist with a PhD in rheumatology from the University of Adelaide.For many years, she worked for the Australian Broadcasting Corporation (ABC) and gained wide attention for reporting on controversial medical topics, particularly the efficacy and safety of statins and psychiatric drugs.Demasi was eventually suspended from her position at ABC in 2016 following controversies over her comprehensive and critical examination of statin drugs and other health risks. After leaving ABC, she continued her career as an independent investigative medical journalist.In this interview, we discuss how science can be weaponized and drug data manipulated or suppressed, even for many common drugs prescribed to millions of Americans.“Psychiatry is a classic example of where pharmaceutical companies have been sponsoring their own trials and burying data and then putting a spin on the medical journal, saying that the drug is safe and effective when the fact is, it's not,” she says.“This is not an exception. This happens commonly. Throughout history, pharmaceutical companies have been sued for designing trials [and] hiding, burying data.”Demasi said she has been censored during her career as a journalist and understands the censorship and the pressures faced by journalists and medical professionals who challenge the data and narratives of the powerful pharmaceutical industry.“COVID was the unmasking of how all of this censorship came about,” she said. “It really was an event that woke people up to just how corrupt the system is at every level, from the media to the academia to the agencies that are meant to protect us to the medical journals.”Views expressed in this video are opinions of the host and the guest, and do not necessarily reflect the views of The Epoch Times.

Bioelectronic medicine is changing how we treat inflammation, autoimmunity, and chronic disease, and this episode shows you exactly how nerve stimulation could redefine human performance, longevity, and brain optimization. You will learn how electricity, neurotransmitters, and targeted neural pathways can replace drugs, control inflammation, and help you hack the vagus nerve with precision instead of guesswork. Watch this episode on YouTube for the full video experience: https://www.youtube.com/@DaveAspreyBPR Host Dave Asprey is joined by Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes for Medical Research at Northwell Health, pioneer of vagus nerve research, and author of The Great Nerve. He is one of the world's most cited scientists in inflammation and neuroscience, and his discoveries created the field now known as bioelectronic medicine. He identified the therapeutic action of anti TNF antibodies, mapped the inflammatory reflex, and revealed how vagus nerve signaling controls immunity. With more than 450 scientific publications and over 120 U.S. patents, he is a trusted authority whose work drives the future of anti-aging, functional medicine, metabolism, and neural therapies. Dr. Tracey and Host Dave Asprey explore how the vagus nerve truly operates, why it contains 200,000 fibers with different functions, and what happens when you stimulate specific pathways that regulate inflammation, HRV, neurotransmitters, and immune signaling. You will learn how nerve impulses transmit information, how voltage gated ion channels shape behavior and biology, and why certain forms of stimulation create measurable improvements in mitochondria, metabolic control, sleep optimization, and emotional regulation. They break down the science behind surgical vagus nerve implants, focused ultrasound, gamma entrainment, cytokine control, and real neuromodulation. They also explore why cold plunging, breath work, HRV training, nootropics, and consumer devices vary so widely in their effects, and how to evaluate these tools with practical biohacking frameworks. You will hear what actually works, what remains experimental, and what the next decade of nerve based therapies could unlock for brain optimization, longevity, ketosis, fasting, supplements, and AI guided interventions in human biology. You'll Learn: • How vagus nerve stimulation reduces inflammation through the inflammatory reflex • Why bioelectronic medicine can replace drugs in autoimmune conditions • How nerve fibers relay electrical and chemical signals inside the body • Why cold immersion, breath work, and HRV training activate specific vagal pathways • How 40 hertz gamma entrainment may influence cognitive decline • Which stimulation methods have clinical validation and which do not • Why high vagal tone is linked to better metabolism, immunity, and emotional stability • What future nerve based technologies may unlock for human performance Dave Asprey is a four-time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade brings you the knowledge to take control of your biology, extend your longevity, and optimize every system in your body and mind. Each episode delivers cutting-edge insights in health, performance, neuroscience, supplements, nutrition, biohacking, emotional intelligence, and conscious living. New episodes are released every Tuesday, Thursday, Friday, and Sunday (BONUS). Dave asks the questions no one else will and gives you real tools to become stronger, smarter, and more resilient. Keywords: Kevin J. Tracey, vagus nerve stimulation, bioelectronic medicine, inflammatory reflex, SetPoint Medical, cytokine control, neuromodulation therapy, autonomic nervous system, HRV optimization, inflammation reduction, rheumatoid arthritis treatment, focused ultrasound therapy, gamma entrainment, mitochondrial signaling, anti-aging science, neural pathway hacking, functional medicine research, immune system regulation, brain and body performance, human longevity science Thank you to our sponsors! -AquaTru | Go to https://aquatruwater.com/daveasprey and save $100 on all AquaTru water purifiers. -MASA Chips | Go to https://www.masachips.com/DAVEASPREY and use code DAVEASPREY for 25% off your first order. -Timeline | Head to https://www.timeline.com/dave to get 10% off your first order. -Calroy | Head to https://calroy.com/dave for an exclusive discount Resources: • Learn More About Kevin's Work: https://feinstein.northwell.edu/institutes-researchers/our-researchers/kevin-j-tracey-md • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Upgrade Collective: https://www.ourupgradecollective.com • Upgrade Labs: https://upgradelabs.com • 40 Years of Zen: https://40yearsofzen.com Timestamps: 0:00 - Trailer 1:12 - Bioelectronic Medicine 3:23 - FDA Approval 6:48 - RA Treatment Explained 11:35 - Vagus Nerve Function 15:12 - External vs Implanted Stimulation 18:06 - Focused Ultrasound 26:11 - Ear Stimulation Science 30:51 - Clinical Evidence 37:10 - Alzheimer's Link 42:15 - Future Applications 46:48 - Cold Exposure Effects 53:51 - Common Misconceptions 55:38 - Final Thoughts See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.